Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients.

Details

Language :

English

Volume :

2

Issue :

1

Database :

Complementary Index

Journal :

BJUI Compass

Publication Type :

Academic Journal

Accession number :

148338356

Full Text :

https://doi.org/10.1002/bco2.42